Background-It has been suggested that the incidence of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), is three or more times higher in northern than in southern Europe. The aim of this EC funded study was to investigage this apparent variation by ascertaining the incidence of IBD across Europe. Methods-For the period 1 October 1991 to 30 September 1993 all new patients diagnosed with IBD were prospectively identified in 20 European centres according to a standard protocol for case ascertainment and definition. Findings-Altogether 2201 patients aged 15 years or more were identified, of whom 1379 were diagnosed as UC (including proctitis), 706 as CD, and 116 as indeterminate. The overall incidence per 100000 at ages 15-64 years (standardised for age and sex) of UC was 10.4 (95% confidence interval (95% CI) 7.6 to 13.1) and that of CD was 5.6 (95% CI 2.8 to 8.3). Rates of UC in northern centres were 40% higher than those in the south (rate ratio (RR)=1.4 (95% CI 1-2 to 1.5)) and for CD they were 80% higher (RR=1.8 (95% CI 1.5 to 2.1)). For UC the highest reported incidence was in Iceland (24.5, 95% CI 17.4 to 31.5) and for CD, Maastricht (The Netherlands; 9.2, 95% CI 6.5 to 11.8) and Amiens (north west France; 9.2, 95% CI 6.3 to 12.2). The lowest incidence of UC was in Almada (southern Portugal) (1.6, 95% CI 0.0 to 3.2) and of CD in Ioannina (north west Greece) (0.9, 95% CI 0.0 to 2.2). An unexpected finding was a difference in the age specific incidence of UC in men and women with the incidence in women but not men declining with age. Interpretation-The higher overall incidence rates in northern centres did not seem to be explained by differences in tobacco consumption or education. Nevertheless, the magnitude of the observed excess for both conditions is less than expected on the basis of previous studies. This may reflect recent increases in the incidence of IBD in southern Europe whereas those in the north may have stabilised.
Ulcerative colitis (UC) and Crohn's disease (CD) are chronic inflammatory bowel diseases (IBDs) of unknown aetiology. Previous studies have suggested that the incidence of these diseases may vary greatly across Europe, with higher rates being found in the north than the south.'-19 For example, the incidence of UC found in Copenhagen, Denmark (8 1 per 100 000) was four times that in Bologna, Italy (1.9 per 100000).2 5 For CD, the rate of 4.1 per 100 000 in Copenhagen was five times that in Galicia, north west Spain (0-8 per 100 000).i8 Such patterns could be due to different study designs (for example, criteria for case definition, methods of case ascertainment, or the time period of investigation) or they could represent real differences which might reflect environmental factors, lifestyle, or genetic susceptibility.
In 1988, around 50 European gastroenterologists and other experts attended a meeting in Rotterdam to plan a study to investigate these patterns. 20 The primary aim of the resultant EC-IBD study was to measure the incidence of UC and CD in centres in the north and south of Europe prospectively using a standard protocol for case ascertainment and data analysis. We report here the epidemiological findings for the two year study period 1 October 1991 to 30 September 1993.
Methods

IDENTIFICATION OF STUDY CENTRES
Potential participating centres for the study were identified at the Rotterdam meeting and from enquiries resulting from an announcement in the Lancet. 2 Investigators interested in participating were invited to take part if their centre satisfied the following requirements: firstly, the centre had a defined catchment area with up to date population data; secondly, diagnostic facilities for high quality endoscopy, radiology, and pathology were available in the catchment area; thirdly, the centre was part of a healthcare system which offered universal cover for primary and specialist services with an established system for referral from primary to secondary care. CIs) were derived from the standard error for the logarithm of the directly standardised rate.24 Data for patients aged over 64 were excluded from calculation of the directly standardised rates due to the problems associated with completeness of case ascertainment among the oldest members of the population and because age specific population counts were not available for older ages in all centres.
To examine the hypothesis of a north-south difference in the incidence of IBD, age adjusted rate ratios (RRs) for northern centres relative to those in the south were estimated by the method of maximum likelihood. This involved fitting a log linear model to the centre, age, and sex specific cases and person-years using the EGRET computer package.25 Approximate x2 tests of significance were obtained from the likelihood ratio and 95% CIs from the standard errors of the model coefficients.
Because of previously documented higher rates of IBD in the immigrant population of Leicester, rates were provided separately for the immigrant and non-immigrant populations.26 For the other centre with a substantial number of immigrants (Beer Sheva), rates could not be calculated separately, as the necessary population data were not provided. Data for Beer Sheva and the immigrant population of Leicester were excluded from calculation of rate ratios for the northern versus southern centres.
Rate ratios for northern versus southern centres were also estimated with additional adjustment for national tobacco consumption (used as a proxy measure of smoking status) and tertiary education (used as a proxy measure for social class and access to health care). Data for these factors and Gross National Product (GNP) were obtained from the 1993 World Development Report.27 For tobacco consumption and tertiary education, three groups were formed, containing roughly equal numbers of centres in each category for the analysis (tertiles). Rate ratios adjusted for these factors were estimated by adding terms to represent their categorical effects to the above mentioned log linear models.
Results
During the two year study period a total of 2201 patients aged 15 years and older were diagnosed with IBD in the 20 centres (due to relocation of investigators in Dublin, cases were recruited during the first year only) with one year follow up forms available for 98% of patients by December 1994. Final diagnosis at one year follow up was UC (including proctitis) in 1379 cases (63%), CD in 706 cases (32%), and indeterminate colitis in the remaining 116 (5%). The initial diagnosis was unchanged for 2119 (96%) cases; 37 cases with an initial diagnosis of indeterminate colitis were changed to UC, and 20 to CD; 16 cases initially diagnosed as UC were changed to CD and conversely nine were changed from CD to UC. The diagnostic methods used for UC were endoscopy in 99% of cases, biopsy in 95%, and radiology in 31%; for CD the corresponding figures were endoscopy in 81% of cases, biopsy in 78%, radiology in 7 1O%, and examination of a resection specimen in 16%. Cases with a final diagnosis of indeterminate colitis are not considered further.
Analysis of the diagnostic methods used, anatomical site, and extent of disease showed little overall difference between centres in the north and south of Europe (data not shown). Likewise, analysis of the presenting symptoms such as bowel frequency, occurrence of rectal bleeding, weight loss, and abdominal pain suggested no systematic differences in severity of symptoms at presentation between cases in the northern and southern centres.
INCIDENCE BY AGE AND SEX Figure 1 shows the age specific incidence rates (per 100 000) for UC including proctitis and CD for all 20 centres combined. For UC, different patterns of incidence were observed for men and women aged 35 and over, with the rates for men remaining fairly constant with increasing age, whereas those for women decreased. Incidence rates for CD were generally lower and were broadly similar for men and women, with rates for both sexes declining with increasing age. Tables I and II show the age and sex specific incidence for UC and CD for each study centre with centres ordered according to degree latitude. Some centre specific rates (for both UC and CD) were based on very few cases and for some centres no cases were observed in certain age groups, particularly in the oldest age group (65+ years) for women. Tables III and IV show the crude and age and sex adjusted incidence rates for ages 15 to 64, for UC and CD, according to study centre. In general, the crude rates were similar to the age and sex adjusted rates. For both diagnostic groups there seemed to be a large degree of Age groups Figure 1 : Age specific incidence rates per 100 000 for ulcerative colitis including procolitis (UC) and Crohn 's disease (CD) in the 20 centres included in the EC-IBD study. (Table V) . After adjustment for both tobacco consumption and tertiary education significantly increased rates in northern versus southern centres were still found for UC and CD in women and for both sexes combined, whereas for both conditions in men the difference in Sabadell (NE Spain) 12-4 (31) 12-9 (9-9-16-0) 6-8 (17) 6-7 (4-6-8-7) 9-6 (48) 9-8 (6-13-5) Braga (N Portugal) 6-1 (10) 6-7 (3-9-9-5)
6-8 (12) 6-6 (4-1-9-0) 6-4 (22) 6-6 (2-9-10-4) Ioannina (NW Greece) 7-9 (13) 8-2 (5-2-11-2) 9-8 (17) 10-4 (7-2-13-7) 8-9 (30) 9-3 (4-9-13-7) incidence of disease between the north and south of Europe was no longer statistically significant.
The relation between centre specific rates and GNP was examined. Northern centres tended to have higher rates of UC and CD and higher levels of GNP (Fig 2) .
As a consequence of the strong relation between incidence of disease, GNP, and latitude, it was not possible to reliably estimate the relative incidence in northern versus southern centres independent of GNP.
Discussion
This is the first study to assess the incidence of UC and CD across Europe prospectively and simultaneously. The overall incidence per 100 000 at ages 15-64 years was 104 for UC and 5.6 for CD. Rates of UC in northern centres were 40% higher than those in the south (RR= 1.4, 95% CI 1.2 to 1.5) and for CD they were 80% higher (RR=1.8, 95% CI 1.5 to 2.1). The observed excess in incidence of UC and CD in northern centres did not seem to be explained by differences in tobacco IBD in Zagreb between 1980 and 1990 disclosed an extremely low annual incidence of both UC (1-5 per 100 000) and CD (0 7 per 100 000) in neighbouring Yugoslavia. 35 36 Further evidence that might support the suggestion that the incidence of IBD is changing across Europe is the emergence of differences in age specific incidence of UC in men and women. Many previous studies have shown that in both sexes incidence of UC peaks in early adult life, sometimes with a second lower peak around the age of 65. 37 38 However, more recent studies have shown less pronounced peaks in age specific incidence in men but not women. 6 16 17 39 In the present study, overall age specific rates of UC among men showed little variation whereas those for women declined with increasing age. This is the first study large enough to show this difference clearly and for it to be significant.
In conclusion, this study suggests a modest excess of incidence of IBD in northern Europe. The magnitude of the observed excess for both conditions is less than expected on the basis of previous studies. This may reflect recent increases in the incidence of IBD in southern Europe whereas those in the north may have stabilised. The aetiology of these conditions is unclear and it is therefore difficult to explain the patterns found. That similar north-south gradients in incidence have also been documented in the United States40 suggests that several factors may be involved, including climate, diet, economic wealth, and development or genetic susceptibility. The collaborative network and the baseline data established under this study provides the framework for further studies to monitor the incidence of IBD, particularly in the low incidence areas, and to examine putative environmental factors around Europe.
